← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Yaso Therapeutics Inc
Phoenix, AZ
$7,233,642
Total funding
6
Grants
Funding over time
peak $1M · FY2006–25$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,233,642 · 6
By mechanism
R44$6,497,313 · 3
R43$584,133 · 2
R41$152,196 · 1
Investigators at Yaso Therapeutics Inc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
Continuing Development of PPCM Vaginal Contraceptive Microbicide$1,000,000
R44 · FY2014 · AI
Continuing Development of PPCM Vaginal Contraceptive Microbicide$1,000,000
R44 · FY2013 · AI
Continuing Preclinical Development of PPCM Vaginal Contraceptive MPT to IND$999,102
R44 · FY2019 · HD
Preclinical development of PPCM vaginal contraceptive to submit IND.$985,250
R44 · FY2017 · HD
Continuing Preclinical Development of PPCM Vaginal Contraceptive MPT to IND$984,778
R44 · FY2020 · HD
Preclinical development of PPCM vaginal contraceptive to submit IND.$982,217
R44 · FY2018 · HD
First in Human Clinical Trial of a Contraceptive MPT YASO GEL$545,966
R44 · FY2025 · HD
Preparation and submission of an IND for PPCM Gel contraceptive$298,521
R43 · FY2022 · HD
Pre-clinical development of PPCM Vaginal Microbicide$285,612
R43 · FY2011 · AI
Development of SAMMA based vaginal microbiocide$152,196
R41 · FY2006 · AI